Bristol Myers Squibb (BMY) Tax Rate (2009 - 2026)
Bristol Myers Squibb (BMY) posted quarterly Tax Rate of 17.31% for Q1 2026, up 18.0% YoY from 14.67% in Q1 2025, and down 33.72% sequentially from 26.12% in Q4 2025.
Bristol Myers Squibb (BMY) Tax Rate (2009 - 2026) Analysis & Trends
Bristol Myers Squibb has disclosed Tax Rate across 18 years of filings, most recently posting 17.31% for Q1 2026.
- In Q1 2026, Tax Rate rose 18.0% year-over-year to 17.31%; the TTM figure through Mar 2026 stood at 24.22% (up 1323.0% YoY), while the FY2025 annual figure was 24.36%, up 3097.0% from the prior year.
- Tax Rate retreated to 17.31% in Q1 2026, from 26.12% in the prior quarter.
- Over the last five years, Tax Rate for BMY reached as high as 56.57% in Q4 2024 and fell as low as 30.95% in Q2 2024.
- The 5-year median for Tax Rate is 18.16% (2023), against an average of 14.45%.
- Annual changes were most pronounced in 2023 — Tax Rate tumbled 3874 bps — and 2024, when it soared 6183 bps.
- A 5-year view of Tax Rate shows it stood at 8.93% in 2022, then jumped by 41 bps to 5.26% in 2023, then jumped by 1176 bps to 56.57% in 2024, then tumbled by 54 bps to 26.12% in 2025, then tumbled by 34 bps to 17.31% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 17.31%, 26.12%, and 29.51% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 16.43% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 12.60% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 32.92% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 78.72% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -20.26% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 12.72% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 21.67% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 14.54% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Bristol Myers Squibb | - | - | 8.07 Bn | 17.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.31 |
| Mar 31, 2026 | 17.31 |
| Dec 31, 2025 | 26.12 |
| Dec 31, 2025 | 26.12 |
| Sep 30, 2025 | 29.51 |
| Sep 30, 2025 | 29.51 |
| Jun 30, 2025 | 25.94 |
| Jun 30, 2025 | 25.94 |
| Mar 31, 2025 | 17.13 |
| Mar 31, 2025 | 17.13 |
| Dec 31, 2024 | 56.57 |
| Dec 31, 2024 | 56.57 |
| Sep 30, 2024 | 27.51 |
| Sep 30, 2024 | 27.51 |
| Jun 30, 2024 | -30.95 |
| Jun 30, 2024 | -30.95 |
| Mar 31, 2024 | -3.40 |
| Mar 31, 2024 | -3.40 |
| Dec 31, 2023 | -5.26 |
| Dec 31, 2023 | -5.26 |